Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Plasma determination of neurofilaments as biomarkers in multiple sclerosis: conclusions of the EMotion Forum].

Revista de neurologia - 1 Aug 2021

Meca-Lallana V, Rodríguez-Antigüedad A, Llaneza M A, Meca-Lallana J E

Abstract excerpt

INTRODUCTION: In the management of multiple sclerosis (MS) there is still a need to identify biomarkers of disease progression, and clinical and subclinical activity. Among them, determination of neurofilament light chain plasma levels (NfL-PM) has shown a possible correlation with clinical course and assessment of therapeutic response in MS patients. However, the determination of NfL-PM has to overcome several...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Disease Progression
Share to Evidence-Based Medicine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Inflammation

Share to Magnetic Resonance Imaging

Share to Multiple Sclerosis

Share to Neurofilament Proteins

Source

Identifiers

PMID: 34291447
DOI: 10.33588/rn.7303.2020691

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Plasma determination of neurofilaments as biomarkers in multiple sclerosis: conclusions of the EMotion Forum].PMID 34291447Read ↗

Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosisSemantic proximity Read ↗

Neurofilament light chain: a biomarker at the crossroads of clarity and confusion for gene-directed therapiesSemantic proximity Read ↗

Neurofilament light chain as a biomarker for neuronal injury in CNS infectionsSemantic proximity Read ↗

Plasma and Cerebrospinal Fluid Neurofilament Light Concentrations Reflect Neuronal Damage in Systemic Lupus ErythematosusSemantic proximity Read ↗

Longitudinal high-frequency blood biomarkers of axonal injury and astrocytic activation after immune reconstitution in multiple sclerosisSemantic proximity Read ↗

Fluid phase biomarkers in multiple sclerosisSemantic proximity Read ↗

The dazzling rise of neurofilaments: Physiological functions and roles as biomarkers.Semantic proximity Read ↗

Increased Disability Progression in rs10191329AA Carriers with Multiple Sclerosis Is Preceded by Neurofilament Light Chain Elevations.Semantic proximity Read ↗

Serum neurofilament light chain is a useful biomarker in pediatric multiple sclerosisSemantic proximity Read ↗

Real-World Serum Neurofilament Light Chain and GFAP in Amyotrophic Lateral Sclerosis on a Commercial ECLIA PlatformSemantic proximity Read ↗

Serum neurofilament light chain, markers of systemic inflammation and clinically relevant depressive symptoms in US adultsSemantic proximity Read ↗

Immune reactivity to neurofilaments and dipeptide repeats in ALS progressionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.